Injective INJ
Current Price
$5.83 +2.48%
$0.3100 Daily Range (5.32%)
$5.60$5.91
$79.79M Daily Volume
912 BTC
Vol/MktCap: 13.72%
Market Performance
0.11% Relative BTC Volume
The total volume of Injective is $79.79M over the past 24 hours, compared to $70.90B total Bitcoin volume.
Hourly Moving Average
8 SMA $5.70 +2.26%
13 SMA $5.71 +2.13%
21 SMA $5.73 +1.76%
55 SMA $5.55 +4.99%
144 SMA $5.75 +1.37%
Price Performance
+2.71% 1 Hour Change
$5.83 from $5.68
-11.80% 7 Day Change
-$0.6880 from $6.52
-24.48% 14 Day Change
-$1.43 from $7.26
-34.12% 30 Day Change
-$1.99 from $7.82
All Time High
March 14, 2024
$52.62 -89.00%
-$46.83 vs. now
24H Change
13.77M USD +2.42%
157 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
13.86M INJ
traded over past 24 hours
13.86% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $5.69, experiencing a slight increase of 1.67% over the past 24 hours. The daily trading range remains tight, with a high of $5.91 and a low of $5.59, indicating a relatively stable short-term price action.
The volume of $78,802,490 represents 13.86% of the market cap, suggesting that trading activity is robust but not exceptionally high, which can indicate either consolidation or a lack of strong buyer interest. The moving averages present a mixed picture; while the 55 SMA shows a positive trend (+2.47%), the shorter SMAs (8, 13, and 21) are trending down, indicating potential short-term weakness.
The 1-hour Relative Strength Index (RSI) is at 36, indicating that INJ may be approaching oversold territory, while the 7-day RSI at 46 suggests a neutral position but with bearish momentum as indicated by the price changes over the past week (-11.76%), two weeks (-26.02%), and month (-35.68%). The substantial decline from its all-time high of $52.62 signals a significant bearish trend over the longer term.
Given the combination of bearish momentum over the longer time frames and short-term consolidation patterns, investors should proceed with caution. While there is potential for short-term gains given the oversold conditions, the overall trend remains negative.
Recommendation: Hold. The current price levels and technical indicators suggest that it may be wise to wait for more definitive bullish signals before entering or adding to positions in Injective.
The volume of $78,802,490 represents 13.86% of the market cap, suggesting that trading activity is robust but not exceptionally high, which can indicate either consolidation or a lack of strong buyer interest. The moving averages present a mixed picture; while the 55 SMA shows a positive trend (+2.47%), the shorter SMAs (8, 13, and 21) are trending down, indicating potential short-term weakness.
The 1-hour Relative Strength Index (RSI) is at 36, indicating that INJ may be approaching oversold territory, while the 7-day RSI at 46 suggests a neutral position but with bearish momentum as indicated by the price changes over the past week (-11.76%), two weeks (-26.02%), and month (-35.68%). The substantial decline from its all-time high of $52.62 signals a significant bearish trend over the longer term.
Given the combination of bearish momentum over the longer time frames and short-term consolidation patterns, investors should proceed with caution. While there is potential for short-term gains given the oversold conditions, the overall trend remains negative.
Recommendation: Hold. The current price levels and technical indicators suggest that it may be wise to wait for more definitive bullish signals before entering or adding to positions in Injective.
Updated 84 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

XRP price ‘looking very bullish’ after 25% weekly gain: How high can it go?
XRP is rebounding strongly from $2, with multiple indicators suggesting upside toward $3.30–$3.50 is possible in the coming weeks.

Morning Minute: Monad's $4B Debut
It was a launch day that beat most expectations for the newest high-speed L1 blockchain.

MSCI, JPMorgan, Strategy, and Why Bitcoin Hyper Is Suddenly On Everyone’s Radar
What to Know: MSCI’s consultation to exclude $BTC-heavy ‘digital asset treasury’ companies from major indexes has turned Strategy into a test case for forced selling…

Doma Protocol Launches Mainnet, Bringing $360B Domain Industry Into DeFi Ecosystem
As tokenization continues expanding into real-world asset classes, blockchain developers are now turning toward one of the internet’s most established markets: domain names.